PTEN and non-small cell lung carcinoma: In pneumonitis-prone mice, the combination did not meaningfully worsen early inflammatory readouts (aside from a week-4 macrophage rise), supporting ATRi + RT testing in PTEN-mutant NSCLC (NSCLC models; not LUAD-restricted) [76].